Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$258.66 - $342.55 $566,465 - $750,184
-2,190 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$268.85 - $341.04 $588,781 - $746,877
2,190 New
2,190 $693,000
Q1 2019

May 14, 2019

SELL
$216.71 - $338.96 $4.5 Million - $7.04 Million
-20,759 Closed
0 $0
Q4 2018

Feb 12, 2019

SELL
$278.5 - $352.75 $4.82 Million - $6.1 Million
-17,306 Reduced 45.46%
20,759 $6.25 Million
Q3 2018

Nov 15, 2018

BUY
$293.51 - $383.83 $6.35 Million - $8.3 Million
21,619 Added 131.45%
38,065 $13.4 Million
Q2 2018

Aug 15, 2018

SELL
$257.52 - $306.91 $36,052 - $42,967
-140 Reduced 0.84%
16,446 $4.77 Million
Q1 2018

May 15, 2018

SELL
$260.13 - $367.91 $195,097 - $275,932
-750 Reduced 4.33%
16,586 $4.54 Million
Q4 2017

Feb 15, 2018

SELL
$307.64 - $344.58 $7.53 Million - $8.44 Million
-24,488 Reduced 58.55%
17,336 $5.52 Million
Q3 2017

Nov 15, 2017

BUY
$281.15 - $329.69 $11.8 Million - $13.8 Million
41,824
41,824 $13.1 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.9B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.